Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
BCPC Stock Forecast 2026-2027
$166.23
Current Price
$5.23B
Market Cap
Buy 2
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to BCPC Price Targets
+40.8%
To High Target of $234.00
+21.8%
To Median Target of $202.50
-1.3%
To Low Target of $164.00
BCPC Price Momentum
+2.5%
1 Week Change
+0.2%
1 Month Change
+8.8%
1 Year Change
+8.4%
Year-to-Date Change
-9.6%
From 52W High of $183.90
+19.4%
From 52W Low of $139.17
📊 TOP ANALYST CALLS
Did BCPC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Balchem is one of their latest high-conviction picks.
Latest BCPC Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, BCPC has a bullish consensus with a median price target of $202.50 (ranging from $164.00 to $234.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $166.23, the median forecast implies a 21.8% upside. This outlook is supported by 2 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
BCPC Analyst Ratings
2
Buy
1
Hold
0
Sell
BCPC Price Target Range
Low
$164.00
Average
$202.50
High
$234.00
Current: $166.23
Latest BCPC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for BCPC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 4, 2026 | HC Wainwright & Co. | Raghuram Selvaraju | Buy | Maintains | $5.16 |
| Feb 24, 2026 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Dec 5, 2025 | Rothschild & Co | Neutral | Initiates | $N/A | |
| Oct 22, 2025 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 4, 2025 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Apr 28, 2025 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Feb 24, 2025 | HC Wainwright & Co. | Buy | Reiterates | $N/A | |
| Nov 4, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Jul 31, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| May 6, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Feb 20, 2024 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Oct 30, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Jul 31, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Jun 5, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Feb 27, 2023 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Nov 7, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Aug 22, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| May 2, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Mar 8, 2022 | HC Wainwright & Co. | Buy | Maintains | $N/A | |
| Feb 22, 2022 | Sidoti & Co. | Buy | Upgrade | $N/A |
Balchem Corporation (BCPC) Competitors
The following stocks are similar to Balchem based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Balchem Corporation (BCPC) Financial Data
Balchem Corporation has a market capitalization of $5.23B with a P/E ratio of 32.9x. The company generates $1.06B in trailing twelve-month revenue with a 15.0% profit margin.
Revenue growth is +8.1% quarter-over-quarter, while maintaining an operating margin of +20.9% and return on equity of +12.7%.
Valuation Metrics
Market Cap
$5.23B
Enterprise Value
$5.30B
P/E Ratio
32.9x
PEG Ratio
3.2x
Price/Sales
4.9x
Growth & Margins
Revenue Growth (YoY)
+8.1%
Gross Margin
+37.3%
Operating Margin
+20.9%
Net Margin
+15.0%
EPS Growth
+8.7%
Financial Health
Cash/Price Ratio
+1.4%
Current Ratio
2.6x
Debt/Equity
14.4x
ROE
+12.7%
ROA
+8.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Balchem Corporation (BCPC) Business Model
About Balchem Corporation
What They Do
Develops specialty performance ingredients for diverse industries.
Business Model
The company operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. It generates revenue by providing specialized ingredients and nutritional solutions for human and animal health, as well as performance gases and chemicals for various industrial applications.
Additional Information
Founded in 1967 and headquartered in New Jersey, Balchem Corporation is a leader in the specialty chemicals sector, emphasizing innovative solutions that enhance health and performance across multiple markets, including food, pharmaceuticals, and industrial uses.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
1,368
CEO
Mr. Theodore Lee Harris
Country
United States
IPO Year
1986
Website
www.balchem.comBalchem Corporation (BCPC) Latest News & Analysis
Latest News
Quick Summary
Balchem Corporation (NASDAQ: BCPC) will participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026.
Why It Matters
Balchem's participation in the conference could signal growth opportunities and attract investor interest, potentially impacting stock performance and market perception.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Balchem Corporation to Participate in the Wells Fargo Industrials Conference on June 10, 2026
1 month ago
Quick Summary
Balchem Corporation (NASDAQ: BCPC) will participate in the Wells Fargo Industrials Conference on June 10, 2026, focusing on their role in health and nutrition markets.
Why It Matters
Balchem's participation in the Wells Fargo Industrials Conference could signal strategic growth opportunities and increased visibility, influencing investor confidence and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
My Top Dividend Growth Picks In Each GICS Sector
1 month ago
Quick Summary
Top dividend growth picks across 11 GICS sectors show strong performance: Sector Winners returned 333% over five years, while Runners-Up gained 83%. Focus on discounted valuations and dividend safety.
Why It Matters
The focus on discounted valuations and strong dividend growth across sectors signals potential for robust returns and reduced risk, enhancing portfolio stability during market fluctuations.
Source: Seeking Alpha
Market Sentiment:
Positive
Quick Summary
Balchem Corporation (BCPC) held its Q1 2026 earnings call, discussing financial performance and strategic initiatives. Further details on revenue and projections were provided.
Why It Matters
The Q1 2026 earnings call indicates Balchem's financial health, performance trends, and future outlook, crucial for assessing investment potential and market positioning.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Balchem Corporation (NASDAQ: BCPC) announced its financial results for Q1 of fiscal 2026, ending March 31, 2026, on April 30, 2026.
Why It Matters
Balchem's Q1 financial results can impact stock performance, influencing investor sentiment and potential future valuations based on revenue growth and profitability trends.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Sherwin-Williams (SHW) reported Q3 earnings of $2.35 per share, surpassing the Zacks estimate of $2.24, and up from $2.25 per share in the same quarter last year.
Why It Matters
Sherwin-Williams beating earnings estimates signals strong performance and potential growth, which can boost investor confidence and impact stock prices positively.
Source: Zacks Investment Research
Market Sentiment:
Positive
Frequently Asked Questions About BCPC Stock
What is Balchem Corporation's (BCPC) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, Balchem Corporation (BCPC) has a median price target of $202.50. The highest price target is $234.00 and the lowest is $164.00.
Is BCPC stock a good investment in 2027?
According to current analyst ratings, BCPC has 2 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $166.23. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for BCPC stock?
Wall Street analysts predict BCPC stock could reach $202.50 in the next 12 months. This represents a 21.8% increase from the current price of $166.23. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Balchem Corporation's business model?
The company operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. It generates revenue by providing specialized ingredients and nutritional solutions for human and animal health, as well as performance gases and chemicals for various industrial applications.
What is the highest forecasted price for BCPC Balchem Corporation?
The highest price target for BCPC is $234.00 from at , which represents a 40.8% increase from the current price of $166.23.
What is the lowest forecasted price for BCPC Balchem Corporation?
The lowest price target for BCPC is $164.00 from at , which represents a -1.3% decrease from the current price of $166.23.
What is the overall BCPC consensus from analysts for Balchem Corporation?
The overall analyst consensus for BCPC is bullish. Out of 2 Wall Street analysts, 2 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $202.50.
How accurate are BCPC stock price projections?
Stock price projections, including those for Balchem Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 17, 2026 2:09 AM UTC